Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: DENTSPLY SIRONA Inc., 3 years.
DENTSPLY SIRONA Inc.
Director
Maravai LifeSciences Holdings Inc.
Director
Avantor Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Avantor Inc. May 7, 202697.6%
-
Maravai LifeSciences Holdings Inc. May 18, 202380.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | Maravai LifeSciences Holdings Inc. | Gift | −46,293 | — | — |
| Jun 9, 2026 | Maravai LifeSciences Holdings Inc. | Gift | +46,293 | — | — |
| Jun 3, 2026 | DENTSPLY SIRONA Inc. | Grant or award | +38,382 | — | — |
| Jun 3, 2026 | DENTSPLY SIRONA Inc. | Gift | −38,382 | — | — |
| Jun 3, 2026 | DENTSPLY SIRONA Inc. | Gift | +38,382 | — | — |
| May 26, 2026 | Maravai LifeSciences Holdings Inc. | Grant or award | +46,293 | $4.38 | $202,763 |
| May 8, 2026 | Avantor Inc. | Open-market purchase | +10,000 | $8.32 | $83,200 |
| May 7, 2026 | Avantor Inc. | Grant or award | +25,270 | — | — |
| Mar 9, 2026 | DENTSPLY SIRONA Inc. | Open-market purchase | +15,000 | $12.45 | $186,750 |
| Mar 3, 2026 | DENTSPLY SIRONA Inc. | Open-market purchase | +22,445 | $14.03 | $314,903 |
| Mar 2, 2026 | DENTSPLY SIRONA Inc. | Open-market purchase | +27,555 | $14.25 | $392,659 |
| Feb 19, 2026 | Avantor Inc. | Open-market purchase | +50,000 | $9.16 | $458,000 |
| Jan 9, 2026 | DENTSPLY SIRONA Inc. | Grant or award | +341 | — | — |
| Dec 8, 2025 | DENTSPLY SIRONA Inc. | Open-market sale | −82,200 | $11.14 | $915,708 |
| Dec 8, 2025 | Maravai LifeSciences Holdings Inc. | Open-market purchase | +48,528 | $3.67 | $178,098 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.